The cystic fibrosis-causing mutation ΔF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis

Patrick H. Thibodeau, John M. Richardson, Wei Wang, Linda Millen, Jarod Watson, Juan L. Mendoza, Kai Du, Sharon Fischman, Hanoch Senderowitz, Gergely L. Lukacs, Kevin Kirk, Philip J. Thomas

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

The deletion of phenylalanine 508 in the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator is directly associated with >90% of cystic fibrosis cases. This mutant protein fails to traffic out of the endoplasmic reticulum and is subsequently degraded by the proteasome. The effects of this mutation may be partially reversed by the application of exogenous osmolytes, expression at low temperature, and the introduction of second site suppressor mutations. However, the specific steps of folding and assembly of full-length cystic fibrosis transmembrane conductance regulator (CFTR) directly altered by the disease-causing mutation are unclear. To elucidate the effects of the ΔF508 mutation, on various steps in CFTR folding, a series of misfolding and suppressor mutations in the nucleotide binding and transmembrane domains were evaluated for effects on the folding and maturation of the protein. The results indicate that the isolated NBD1 responds to both the ΔF508 mutation and intradomain suppressors of this mutation. In addition, identification of a novel second site suppressor of the defect within the second transmembrane domain suggests that ΔF508 also effects interdomain interactions critical for later steps in the biosynthesis of CFTR.

Original languageEnglish (US)
Pages (from-to)35825-35835
Number of pages11
JournalJournal of Biological Chemistry
Volume285
Issue number46
DOIs
StatePublished - Nov 12 2010

Fingerprint

Cystic Fibrosis Transmembrane Conductance Regulator
Genetic Suppression
Cystic Fibrosis
Mutation
Nucleotides
Biosynthesis
Protein Folding
Proteasome Endopeptidase Complex
Mutant Proteins
Phenylalanine
Endoplasmic Reticulum
Defects
Temperature
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

The cystic fibrosis-causing mutation ΔF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. / Thibodeau, Patrick H.; Richardson, John M.; Wang, Wei; Millen, Linda; Watson, Jarod; Mendoza, Juan L.; Du, Kai; Fischman, Sharon; Senderowitz, Hanoch; Lukacs, Gergely L.; Kirk, Kevin; Thomas, Philip J.

In: Journal of Biological Chemistry, Vol. 285, No. 46, 12.11.2010, p. 35825-35835.

Research output: Contribution to journalArticle

Thibodeau, PH, Richardson, JM, Wang, W, Millen, L, Watson, J, Mendoza, JL, Du, K, Fischman, S, Senderowitz, H, Lukacs, GL, Kirk, K & Thomas, PJ 2010, 'The cystic fibrosis-causing mutation ΔF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis', Journal of Biological Chemistry, vol. 285, no. 46, pp. 35825-35835. https://doi.org/10.1074/jbc.M110.131623
Thibodeau, Patrick H. ; Richardson, John M. ; Wang, Wei ; Millen, Linda ; Watson, Jarod ; Mendoza, Juan L. ; Du, Kai ; Fischman, Sharon ; Senderowitz, Hanoch ; Lukacs, Gergely L. ; Kirk, Kevin ; Thomas, Philip J. / The cystic fibrosis-causing mutation ΔF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. In: Journal of Biological Chemistry. 2010 ; Vol. 285, No. 46. pp. 35825-35835.
@article{a46db79bab534a45b62724a6ea235a21,
title = "The cystic fibrosis-causing mutation ΔF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis",
abstract = "The deletion of phenylalanine 508 in the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator is directly associated with >90{\%} of cystic fibrosis cases. This mutant protein fails to traffic out of the endoplasmic reticulum and is subsequently degraded by the proteasome. The effects of this mutation may be partially reversed by the application of exogenous osmolytes, expression at low temperature, and the introduction of second site suppressor mutations. However, the specific steps of folding and assembly of full-length cystic fibrosis transmembrane conductance regulator (CFTR) directly altered by the disease-causing mutation are unclear. To elucidate the effects of the ΔF508 mutation, on various steps in CFTR folding, a series of misfolding and suppressor mutations in the nucleotide binding and transmembrane domains were evaluated for effects on the folding and maturation of the protein. The results indicate that the isolated NBD1 responds to both the ΔF508 mutation and intradomain suppressors of this mutation. In addition, identification of a novel second site suppressor of the defect within the second transmembrane domain suggests that ΔF508 also effects interdomain interactions critical for later steps in the biosynthesis of CFTR.",
author = "Thibodeau, {Patrick H.} and Richardson, {John M.} and Wei Wang and Linda Millen and Jarod Watson and Mendoza, {Juan L.} and Kai Du and Sharon Fischman and Hanoch Senderowitz and Lukacs, {Gergely L.} and Kevin Kirk and Thomas, {Philip J.}",
year = "2010",
month = "11",
day = "12",
doi = "10.1074/jbc.M110.131623",
language = "English (US)",
volume = "285",
pages = "35825--35835",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "46",

}

TY - JOUR

T1 - The cystic fibrosis-causing mutation ΔF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis

AU - Thibodeau, Patrick H.

AU - Richardson, John M.

AU - Wang, Wei

AU - Millen, Linda

AU - Watson, Jarod

AU - Mendoza, Juan L.

AU - Du, Kai

AU - Fischman, Sharon

AU - Senderowitz, Hanoch

AU - Lukacs, Gergely L.

AU - Kirk, Kevin

AU - Thomas, Philip J.

PY - 2010/11/12

Y1 - 2010/11/12

N2 - The deletion of phenylalanine 508 in the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator is directly associated with >90% of cystic fibrosis cases. This mutant protein fails to traffic out of the endoplasmic reticulum and is subsequently degraded by the proteasome. The effects of this mutation may be partially reversed by the application of exogenous osmolytes, expression at low temperature, and the introduction of second site suppressor mutations. However, the specific steps of folding and assembly of full-length cystic fibrosis transmembrane conductance regulator (CFTR) directly altered by the disease-causing mutation are unclear. To elucidate the effects of the ΔF508 mutation, on various steps in CFTR folding, a series of misfolding and suppressor mutations in the nucleotide binding and transmembrane domains were evaluated for effects on the folding and maturation of the protein. The results indicate that the isolated NBD1 responds to both the ΔF508 mutation and intradomain suppressors of this mutation. In addition, identification of a novel second site suppressor of the defect within the second transmembrane domain suggests that ΔF508 also effects interdomain interactions critical for later steps in the biosynthesis of CFTR.

AB - The deletion of phenylalanine 508 in the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator is directly associated with >90% of cystic fibrosis cases. This mutant protein fails to traffic out of the endoplasmic reticulum and is subsequently degraded by the proteasome. The effects of this mutation may be partially reversed by the application of exogenous osmolytes, expression at low temperature, and the introduction of second site suppressor mutations. However, the specific steps of folding and assembly of full-length cystic fibrosis transmembrane conductance regulator (CFTR) directly altered by the disease-causing mutation are unclear. To elucidate the effects of the ΔF508 mutation, on various steps in CFTR folding, a series of misfolding and suppressor mutations in the nucleotide binding and transmembrane domains were evaluated for effects on the folding and maturation of the protein. The results indicate that the isolated NBD1 responds to both the ΔF508 mutation and intradomain suppressors of this mutation. In addition, identification of a novel second site suppressor of the defect within the second transmembrane domain suggests that ΔF508 also effects interdomain interactions critical for later steps in the biosynthesis of CFTR.

UR - http://www.scopus.com/inward/record.url?scp=78149270037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149270037&partnerID=8YFLogxK

U2 - 10.1074/jbc.M110.131623

DO - 10.1074/jbc.M110.131623

M3 - Article

VL - 285

SP - 35825

EP - 35835

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 46

ER -